Table: Oncolys Biopharma - 6-MTH parent results
Aug 2 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 621 mln 90 mln
(+586.6 pct) (+354.4 pct)
Operating loss 275 mln loss 643 mln
Recurring loss 271 mln loss 639 mln
Net loss 273 mln loss 641 mln
EPS loss 20.07 yen loss 57.89 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T